<strong>Relationship between efficacy and safety of osimertinib blood concentration in patients with EGFR mutation-positive lung cancer</strong>

○Yasuhisa Hashino

[27P2-pm2-123] Relationship between efficacy and safety of osimertinib blood concentration in patients with EGFR mutation-positive lung cancer

○Yasuhisa Hashino¹, Tae Hatsuyama², Kuninori Iwayama ¹, Hideki Sato¹, Takaki Toda¹ (1. Faculty of Pharmaceutical Sciences, Hokkaido University of Science, Hokkaido, 2. Department Pharmacy , Sapporo Minami-sanjo Hospital.)

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.

Presentation information

[27P2-pm2] Clinical Pharmacy 3

[27P2-pm2-123] Relationship between efficacy and safety of osimertinib blood concentration in patients with EGFR mutation-positive lung cancer

Password